PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
H.R. 2617: Consolidated Appropriations Act, 2023 (P.L. 117-328) H.R. 5376: Inflation Reduction Act of 2022 (P.L. 117-169) H.R. 6833: Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 (P.L. 117-180) S. 4543: James M. Inhofe National Defense Authorization Act for Fiscal Year 2023 H.R. ____: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. ____: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024 H.R.___: National Defense Authorization Act for Fiscal Year 2024 S._____: National Defense Authorization Act for Fiscal Year 2024 S._____: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 S. ____: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024 FY 2024 Presidents Budget Request
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER MIRANDA BRYANT | — |
| NATALIE BURKHALTER | — |
| RANDY BURKHOLDER | — |
| ANNE ELIZABETH ESPOSITO | — |
| BART FORSYTH | — |
| PAUL GAGE | — |
| KELLY GOLDBERG | — |
| JAIMON M JACKSON | — |
| RYAN KAAT | — |
| DAVID KORN | — |
| NICHOLAS LISOWSKI | — |
| COLLEEN MALONEY | — |
| JOHN NAPPI | — |
| TOM O'BRIEN | — |
| ANNE PRITCHETT | — |
| LORI REILLY | — |
| CORBIN SANTO New | Legislative Intern - Sen. Evan Bayh |
| JOCELYN ULRICH | — |
| SCOTT WOODS | — |
| MICHAEL PAUL WOODY | — |
Copyright/Patent/Trademark CPT
S. 79: Interagency Patent Coordination and Improvement Act of 2023 - Provisions related to Interagency Task Force S. 142: Preserve Access to Affordable Generics and Biosimilars Act - Provisions related to patent settlements S. 150: Affordable Prescriptions for Patients Act of 2023 - Provisions related to intellectual property and patents S. 574: Increasing Prescription Drug Competition Act - Patent-related policy issues Biopharmaceutical innovation and patent policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues Patent use codes policy issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| NATALIE BURKHALTER | — |
| ANNE ELIZABETH ESPOSITO | — |
| BART FORSYTH | — |
| PAUL GAGE | — |
| KELLY GOLDBERG | — |
| RYAN KAAT | — |
| DAVID KORN | — |
| JOHN NAPPI | — |
| LORI REILLY | — |
| ZACH SENTEMENTES | — |
| JOCELYN ULRICH | — |
Health Issues HCR
H.R. 198: Drug Pricing Transparency and Accountability Act - Provisions related to the 340B Program H.R. 1790: Biologics Competition Act of 2023 - Directs the Secretary of Health and Human Services to evaluate the extent to which the substitution of interchangeable biological products is impacted by differences between the system for determining a biological product to be interchangeable and the system for assigning therapeutic equivalence ratings to drugs, and for other purposes H.R. 4390: Protect 340B Act - Provisions related to 340B Program H.R. 5376: Inflation Reduction Act of 2022 (P.L. 117-169) H.R. 7032: Increasing Transparency in Generic Drug Application Act - Requires the Food and Drug Administration to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why) S. 148: Stop STALLING Act - Provisions related to citizen petitions S. 315: Taxpayer Research And Contributions Knowledge Act of 2023 or TRACK Act of 2023 - Directs the Secretary of Health and Human Services and other Federal officials to compile into a searchable database information relating to Federal support for biomedical research and development, and for other purposes S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 - Provisions related to drug pricing S. 2076: PASTEUR Act of 2021 - Provisions related to antimicrobial resistance policy issues S. 3799: Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act or PREVENT Pandemics Act Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA) Cancer Moonshot Initiative 21st Century Cures 2.0 Drug cost and pricing policy issues Principles for drug pricing reform Drug importation policy issues Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance (AMR) policy issues Mental health policy issues High deductible health plans/HSA policy issues Supply chain and foreign manufacturing policy issues Real world evidence policy issues Clinical trial diversity policy issues Prescription drug abuse policy issues 340B drug discount program policy issues Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues COVID-19 policy issues Pandemic preparedness policy issues Defense Production Act policy issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER MIRANDA BRYANT | — |
| NATALIE BURKHALTER | — |
| RANDY BURKHOLDER | — |
| ANNE ELIZABETH ESPOSITO | — |
| BART FORSYTH | — |
| PAUL GAGE | — |
| KELLY GOLDBERG | — |
| JAIMON M JACKSON | — |
| RYAN KAAT | — |
| DAVID KORN | — |
| NICHOLAS LISOWSKI | — |
| COLLEEN MALONEY | — |
| JOHN NAPPI | — |
| TOM O'BRIEN | — |
| ANNE PRITCHETT | — |
| LORI REILLY | — |
| CORBIN SANTO New | Legislative Intern - Sen. Evan Bayh |
| BRIDGETT TAYLOR | — |
| JOCELYN ULRICH | — |
| ANNIE WOERPEL | — |
| SCOTT WOODS | — |
| MICHAEL PAUL WOODY | — |
| SYLVIA YU | — |
Medicare/Medicaid MMM
H.R. 485: Protecting Health Care for All Patients Act of 2023 - Prohibits all federal health care programs from using prices that are based on quality-adjusted life years to determine relevant thresholds for coverage, reimbursements, or incentive programs H.R. 830: Help Ensure Lower Patient Copays Act or the HELP Copays Act - Requires health insurance plans to apply certain payments made by, or on behalf of, a plan enrollee toward a plan's cost-sharing requirements H.R. 5376: Inflation Reduction Act of 2022 (P.L. 117-169) S. 127: Pharmacy Benefit Manager Transparency Act of 2023 - Provisions related to PBMs National coverage determination policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Rebate policy issues Insulin policy issues Pharmacy Benefit Manager reform and policy issues Value-based purchasing arrangements policy issues Anti-Kickback Statute policy issues Center for Medicare and Medicaid Innovation (CMMI) and model policy issues Medicaid rebates and waiver policy issues CMS Guidance on the Medicare Drug Price Negotiation Program: Initial Memorandum [ ] IPAY 2026 and Solicitation of Comments CMS Guidance on Medicare Part B and D Inflation Rebates
| Lobbyist | Covered position, as disclosed |
|---|---|
| SANDY AHN | — |
| JENNIFER MIRANDA BRYANT | — |
| NATALIE BURKHALTER | — |
| RANDY BURKHOLDER | — |
| ANNE ELIZABETH ESPOSITO | — |
| BART FORSYTH | — |
| PAUL GAGE | — |
| KELLY GOLDBERG | — |
| JUDITH HARON New | None |
| JAIMON M JACKSON | — |
| NICHOLAS LISOWSKI | — |
| COLLEEN MALONEY | — |
| LORI REILLY | — |
| CORBIN SANTO New | Legislative Intern - Sen. Evan Bayh |
| BRIDGETT TAYLOR | — |
| JOCELYN ULRICH | — |
| JULIE WAGNER | — |
| ANNIE WOERPEL | — |
| SCOTT WOODS | — |
| SYLVIA YU | — |
Trade (domestic/foreign) TRD
S. 113: Prescription Pricing for the People Act of 2023 - Provisions related to medical supply chains and prescription drug pricing transparency policy issues S. 2495: Protecting our Pharmaceutical Supply Chain from China Act of 2021 - Provisions related to medical supply chain policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues China outbound investment policy issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| NATALIE BURKHALTER | — |
| ANNE ELIZABETH ESPOSITO | — |
| BART FORSYTH | — |
| PAUL GAGE | — |
| KELLY GOLDBERG | — |
| RYAN KAAT | — |
| DAVID KORN | — |
| NICHOLAS LISOWSKI | — |
| ANNE PRITCHETT | — |
| LORI REILLY | — |
| ZACH SENTEMENTES | — |
| ANNIE WOERPEL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.